Literature DB >> 31009792

Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017.

Suk Seo1, Michael J Silverberg2, Leo B Hurley2, Joanna Ready3, Varun Saxena4, David Witt5, C Bradley Hare6, Jamila H Champsi4, Daniel G Korn7, Mary Patricia Pauly8, Scott Chamberland9, Jennifer B Lai5, Julia L Marcus10.   

Abstract

Strategic planning for hepatitis C virus (HCV) screening and treatment requires up-to-date information on the prevalence of HCV spontaneous clearance. Published estimates of HCV spontaneous clearance range from 15% to 60%.1-3 We conducted an observational study over 20 years to evaluate trends in the prevalence of HCV spontaneous clearance. Our goals were to estimate the proportion of HCV-antibody-positive patients who were viremic, and to identify factors associated with viremia, thus facilitating prediction of the number of patients needing treatment.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID： 31009792      PMCID： PMC6801008          DOI： 10.1016/j.cgh.2019.04.035

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  7 in total

1.  Natural course of acute hepatitis C: a long-term prospective study.

Authors:  T Santantonio; E Sinisi; A Guastadisegni; C Casalino; M Mazzola; A Gentile; G Leandro; G Pastore
Journal:  Dig Liver Dis       Date:  2003-02       Impact factor: 4.088

2.  Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers.

Authors:  Monica A Konerman; Mary Thomson; Kristen Gray; Meghan Moore; Hetal Choxi; Elizabeth Seif; Anna S F Lok
Journal:  Hepatology       Date:  2017-09-14       Impact factor: 17.425

3.  Prevalence of hepatitis C virus antibodies in systemic lupus erythematosus.

Authors:  Pazhanivel Mohan; Muthusubramaniyan Rajasekaran; Porkodi Ramanathan; Jayanthi Venkataraman
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-12       Impact factor: 2.566

4.  Factors associated with spontaneous clearance of chronic hepatitis C virus infection.

Authors:  Naomi Bulteel; Prasanna Partha Sarathy; Ewan Forrest; Adrian J Stanley; Hamish Innes; Peter R Mills; Heather Valerio; Rory N Gunson; Celia Aitken; Jude Morris; Ray Fox; Stephen T Barclay
Journal:  J Hepatol       Date:  2016-05-04       Impact factor: 25.083

Review 5.  Natural history of hepatitis C.

Authors:  David L Thomas; Leonard B Seeff
Journal:  Clin Liver Dis       Date:  2005-08       Impact factor: 6.126

6.  The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis.

Authors:  Richard Conway; Michele F Doran; Finbar D O'Shea; Brendan Crowley; Gaye Cunnane
Journal:  Clin Rheumatol       Date:  2014-04-13       Impact factor: 2.980

7.  Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers.

Authors:  Mariana Castrejón; Kara W Chew; Marjan Javanbakht; Romney Humphries; Sammy Saab; Jeffrey D Klausner
Journal:  Open Forum Infect Dis       Date:  2017-05-27       Impact factor: 3.835
  7 in total
  9 in total

1.  Using Public Health Surveillance Data to Determine Hepatitis C Virus Exposure Among Live-Born Infants in Tennessee, 2013-2017.

Authors:  Heather Wingate; Lindsey Sizemore; Jennifer Black; Zachary Heth; Pamela Talley; Stephen W Patrick; Carolyn Wester
Journal:  Public Health Rep       Date:  2021-08-17       Impact factor: 3.117

2.  Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.

Authors:  Shelley N Facente; Rachel Grinstein; Roberta Bruhn; Zhanna Kaidarova; Erin Wilson; Jennifer Hecht; Katie Burk; Eduard Grebe; Meghan D Morris
Journal:  PLoS One       Date:  2022-05-11       Impact factor: 3.752

3.  Association Between Time to First RNA-Negative Test Result Among People With Hepatitis C Virus Infection and Homelessness or Testing at a Correctional or Substance Use Treatment Facility, New York City.

Authors:  Miranda S Moore; Angelica Bocour
Journal:  Public Health Rep       Date:  2021-10-25       Impact factor: 3.117

4.  Vital Signs: Newly Reported Acute and Chronic Hepatitis C Cases - United States, 2009-2018.

Authors:  A Blythe Ryerson; Sarah Schillie; Laurie K Barker; Benjamin A Kupronis; Carolyn Wester
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-10       Impact factor: 17.586

5.  CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020.

Authors:  Sarah Schillie; Carolyn Wester; Melissa Osborne; Laura Wesolowski; A Blythe Ryerson
Journal:  MMWR Recomm Rep       Date:  2020-04-10

6.  Quantitative differences between intra-host HCV populations from persons with recently established and persistent infections.

Authors:  Pelin B Icer Baykal; James Lara; Yury Khudyakov; Alex Zelikovsky; Pavel Skums
Journal:  Virus Evol       Date:  2020-12-30

7.  The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis.

Authors:  Ghobad Moradi; Marzieh Soheili; Roya Rashti; Hojat Dehghanbanadaki; Elham Nouri; Farima Zakaryaei; Elnaz Ezzati Amini; Sheno Baiezeedi; Sanaz Ahmadi; Yousef Moradi
Journal:  Eur J Med Res       Date:  2022-03-26       Impact factor: 2.175

8.  Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009-2016).

Authors:  Aidan M Nikiforuk; Mohammad Ehsanul Karim; David M Patrick; Agatha N Jassem
Journal:  BMC Public Health       Date:  2021-07-13       Impact factor: 3.295

9.  Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system.

Authors:  Marjan Javanbakht; Roxanne Archer; Jeffrey Klausner
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.